Huai-Hung D Kao

Title: Innovations of Huai-Hung D Kao

Introduction

Huai-Hung D Kao is a prominent inventor based in Syosset, NY (US), known for his significant contributions to the pharmaceutical industry. He holds a total of 15 patents, showcasing his innovative approach to pain management and opioid formulations. His work has had a profound impact on the development of controlled-release medications.

Latest Patents

Among his latest patents, the "Oxymorphone controlled release formulations" stands out. This invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone, which produces a mean minimum blood plasma level 12 to 24 hours after dosing, providing sustained pain relief. Another notable patent is the "Abuse-resistant controlled-release opioid dosage form." This invention features abuse-resistant, controlled release opioid tablets that include an opioid antagonist, such as naloxone, at a level sufficient to suppress the euphoric effect of the opioid if the combination is crushed. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of the opioid antagonist when taken normally.

Career Highlights

Throughout his career, Huai-Hung D Kao has worked with leading pharmaceutical companies, including Purdue Pharma L.P. and Endo Pharmaceuticals Inc. His expertise in developing innovative drug formulations has positioned him as a key figure in the industry.

Collaborations

He has collaborated with notable professionals in the field, including Frank S Caruso and Anand R Baichwal. These partnerships have further enhanced his contributions to pharmaceutical innovations.

Conclusion

Huai-Hung D Kao's work in the field of controlled-release opioid formulations has made a significant impact on pain management therapies. His innovative patents reflect his dedication to improving patient care and addressing the challenges associated with opioid use.